Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

CCB Opens RMB Private Equity Fund for Healthcare

publication date: Oct 1, 2009

China Construction Bank (CCB) is building a 2.6 billion RMB ($380 million) private equity fund which will invest in expanding-to-mature China healthcare companies that have not made their IPOs. The goal of the fund is to invest in companies at a price-earnings ratio of ten. RMB-denominated funds are becoming an increasingly important factor in China’s investment world as the international investment environment changes. More details...

Stock Symbol: (HK: 0939)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital